ProShare Advisors’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

ProShare Advisors’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-478	Closed	-$35K	–	1760
2016 Q3	$35K	Sell	478 -84	-15%	-$6.49K	﹤0.01%	1448
2016 Q2	$45K	Buy	562 +10	+2%	+$1.91K	﹤0.01%	1556
2016 Q1	$149K	Sell	552 -52	-9%	-$16.6K	﹤0.01%	1470
2015 Q4	$364K	Buy	+604	New	+$409K	﹤0.01%	1194

Other funds holding SRRA

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.2B AUM 2.09% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ProShare Advisors's SRRA Position: Q4 2016 in Review

ProShare Advisors sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q4 2016, closing a stake of 478 shares — an estimated $35K sold.

ProShare Advisors first reported a position in SRRA in Q4 2015 and held it in 4 quarters. The position peaked at $364K in Q4 2015. 36 funds tracked by Wall St. Rank hold SRRA as of Q4 2016.

ProShare Advisors reported no remaining Sierra Oncology, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
ProShare Advisors sold 478 Sierra Oncology, Inc. Common Stock shares in Q4 2016, an estimated $35K.
ProShare Advisors first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 4 quarters.
ProShare Advisors's Sierra Oncology, Inc. Common Stock position peaked at $364K in Q4 2015.
36 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q4 2016.

Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.